Company Filing History:
5 out of 106 
3 out of 16,338 
1 out of 206 Years Active: 1989-2002
Title: Michael Ernest Pierce: Innovator in HIV Research
Introduction
Michael Ernest Pierce is a notable inventor based in Wilmington, Delaware. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as inhibitors for HIV reverse transcriptase. With a total of 10 patents to his name, Pierce's work has had a profound impact on HIV treatment.
Latest Patents
Among his latest patents is the "Practical synthesis of benzoxazinones useful as HIV reverse transcriptase inhibitors." This invention describes novel methods for synthesizing benzoxazinone compounds that are particularly effective in treating HIV. The benzoxazinone compounds developed by Pierce are crucial in the fight against the human immunodeficiency virus.
Career Highlights
Throughout his career, Michael Ernest Pierce has worked with prominent companies such as DuPont Pharmaceuticals Company and E.I. du Pont de Nemours and Company. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Pierce has collaborated with esteemed colleagues, including Lilian Alicia Radesca and Paul E. Aldrich. These partnerships have further enhanced his research and development efforts in the field of HIV treatment.
Conclusion
Michael Ernest Pierce stands out as an influential inventor in the realm of HIV research. His innovative patents and collaborations have significantly advanced the understanding and treatment of this critical disease.